دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Metformin and Cancer: Solutions to a Real-World Evidence Failure
Oriana Hoi Yun Yu; Samy Suissa
doi : 10.2337/dci22-0047
COVID-19 and Rising Incidence of Diabetes: Despite Evolving Data, an Enigma Still to Be Solved
William T. Cefalu
doi : 10.2337/dci22-0067
Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk
Paul W. Franks
doi : 10.2337/dci22-0066
Delivering on the Promise of Technology to Augment Behavioral Interventions in Type 2 Diabetes
Anna R. Kahkoska; Angelica Cristello Sarteau; Matthew J. Crowley
doi : 10.2337/dci23-0009
Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland
Paul M. McKeigue; Stuart McGurnaghan; Luke Blackbourn; Louise E. Bath; David A. McAllister; Thomas M. Caparrotta; Sarah H. Wild; Simon N. Wood; Diane Stockton; Helen M. Colhoun
doi : 10.2337/dc22-0385
Questionnaire-Based Polyexposure Assessment Outperforms Polygenic Scores for Classification of Type 2 Diabetes in a Multiancestry Cohort
Farida S. Akhtari; Dillon Lloyd; Adam Burkholder; Xiaoran Tong; John S. House; Eunice Y. Lee; John Buse; Shepherd H. Schurman; David C. Fargo; Charles P. Schmitt; Janet Hall; Alison A. Motsinger-Reif
doi : 10.2337/dc22-0295
Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study
Naomi Holman; Emma Barron; Bob Young; Edward W. Gregg; Kamlesh Khunti; Jonathan Valabhji; Naveed Sattar
doi : 10.2337/dc22-0670
Association and Interaction of Genetics and Area-Level Socioeconomic Factors on the Prevalence of Type 2 Diabetes and Obesity
Sara J. Cromer; Chirag M. Lakhani; Josep M. Mercader; Timothy D. Majarian; Philip Schroeder; Joanne B. Cole; Jose C. Florez; Chirag J. Patel; Alisa K. Manning; Sherri-Ann M. Burnett-Bowie; Jordi Merino; Miriam S. Udler
doi : 10.2337/dc22-1954
Incidence, Severity, and Presentation of Type 2 Diabetes in Youth During the First and Second Year of the COVID-19 Pandemic
Sabitha Sasidharan Pillai; Phinnara Has; Jose Bernardo Quintos; Monica Serrano Gonzalez; Vania L. Kasper; Lisa Swartz Topor; Meghan E. Fredette
doi : 10.2337/dc22-1702
An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial
You-Bin Lee; Gyuri Kim; Ji Eun Jun; Hyunjin Park; Woo Je Lee; You-Cheol Hwang; Jae Hyeon Kim
doi : 10.2337/dc22-1929
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
Huan Wang; Ruth L.M. Cordiner; Yu Huang; Louise Donnelly; Simona Hapca; Andrew Collier; John McKnight; Brian Kennon; Fraser Gibb; Paul McKeigue; Sarah H. Wild; Helen Colhoun; John Chalmers; John Petrie; Naveed Sattar; Thomas MacDonald; Rory J. McCrimmon; Daniel R. Morales; Ewan R. Pearson; Scottish Diabetes Research Network Epidemiology Group
doi : 10.2337/dc22-1238
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Siham Abdelgani; Ahmed Khattab; John Adams; Mohamed Abu-Farha; Guisepe Daniele; Fahd Al-Mulla; Stefano Del Prato; Ralph A. DeFronzo; Muhammad Abdul-Ghani
doi : 10.2337/dc22-0885
Physical Activity and Insulin Sensitivity Independently Attenuate the Effect of FTO rs9939609 on Obesity
Mette K. Andersen; Lars Ängquist; Jette Bork-Jensen; Anna E. Jonsson; Sara E. Stinson; Camilla H. Sandholt; Malte Thodberg; Laura Maarit Pikkupeura; Emily L. Ongstad; Niels Grarup; Arne Astrup; Oluf Pedersen; Kristine Williams; Romain Barrès; Thorkild I.A. Sørensen; Allan Linneberg; Joseph Grimsby; Christopher J. Rhodes; Torben Hansen
doi : 10.2337/dc22-2078
Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data
Vera Lehmann; Simon Föll; Martin Maritsch; Eva van Weenen; Mathias Kraus; Sophie Lagger; Katja Odermatt; Caroline Albrecht; Elgar Fleisch; Thomas Zueger; Felix Wortmann; Christoph Stettler
doi : 10.2337/dc22-2290
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Tim Heise; J. Hans DeVries; Shweta Urva; Jing Li; Edward J. Pratt; Melissa K. Thomas; Kieren J. Mather; Chrisanthi A. Karanikas; Julia Dunn; Axel Haupt; Zvonko Milicevic; Tamer Coskun
doi : 10.2337/dc22-1710
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
William E. Russell; Brian N. Bundy; Mark S. Anderson; Laura A. Cooney; Stephen E. Gitelman; Robin S. Goland; Peter A. Gottlieb; Carla J. Greenbaum; Michael J. Haller; Jeffrey P. Krischer; Ingrid M. Libman; Peter S. Linsley; S. Alice Long; Sandra M. Lord; Daniel J. Moore; Wayne V. Moore; Antoinette M. Moran; Andrew B. Muir; Philip Raskin; Jay S. Skyler; John M. Wentworth; Diane K. Wherrett; Darrell M. Wilson; Anette-Gabriele Ziegler; Kevan C. Herold; Type 1 Diabetes TrialNet Study Group
doi : 10.2337/dc22-2200
Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study
Steffen U. Thorsen; Xiang Liu; Yachana Kataria; Thomas Mandrup-Poulsen; Simranjeet Kaur; Ulla Uusitalo; Suvi M. Virtanen; Jill M. Norris; Marian Rewers; William Hagopian; Jimin Yang; Jin-Xiong She; Beena Akolkar; Stephen Rich; Carin Andrén Aronsson; Åke Lernmark; Anette-Gabriele Ziegler; Jorma Toppari; Jeffrey Krischer; Hemang M. Parikh; Christina Ellervik; Jannet Svensson; TEDDY Study Group
doi : 10.2337/dc22-1359
Impact of Early Life Factors on Metabolic Phenotypes of Obesity in Preschool Children
Zijun Liao; Xianghui Xie; Jing Wang; Yiren Chen; Ting Zhang; Gongshu Liu; Fangfang Chen
doi : 10.2337/dc22-1851
Incidence of LADA and Type 2 Diabetes in Relation to Tobacco Use and Genetic Susceptibility to Type 2 Diabetes and Related Traits: Findings From a Swedish Case-Control Study and the Norwegian HUNT Study
Jessica Edstorp; Emma Ahlqvist; Lars Alfredsson; Dina Mansour Aly; Valdemar Grill; Bahareh Rasouli; Elin P. Sørgjerd; Tiinamaija Tuomi; Bjørn O. Åsvold; Sofia Carlsson
doi : 10.2337/dc22-2284
CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study
Anne Gedebjerg; Mette Bjerre; Alisa Devedzic Kjaergaard; Jens Steen Nielsen; Jørgen Rungby; Ivan Brandslund; Michael Maeng; Henning Beck-Nielsen; Allan Vaag; Henrik Toft Sørensen; Troels Krarup Hansen; Reimar Wernich Thomsen
doi : 10.2337/dc22-1353
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis
Hertzel C. Gerstein; Shun-Fu Lee; Guillaume Paré; M. Angelyn Bethel; Helen M. Colhoun; Anastasia Hoover; Mark Lakshmanan; Yanzhu Lin; Valentino Pirro; Hui-Rong Qian; Giacomo Ruotolo; Lars Ryden; Jonathan M. Wilson; Kevin L. Duffin
doi : 10.2337/dc22-2397
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
Christof M. Kazda; Juliana M. Bue-Valleskey; Jenny Chien; Qianyi Zhang; Emmanuel Chigutsa; William Landschulz; Paula Wullenweber; Axel Haupt; Dominik Dahl
doi : 10.2337/dc22-2395
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
Juliana M. Bue-Valleskey; Christof M. Kazda; Chenchen Ma; Jenny Chien; Qianyi Zhang; Emmanuel Chigutsa; William Landschulz; Axel Haupt; Juan P. Frias
doi : 10.2337/dc22-2396
Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm
Dariusz Tarasewicz; Andrew J. Karter; Noel Pimentel; Howard H. Moffet; Khanh K. Thai; David Schlessinger; Oleg Sofrygin; Ronald B. Melles
doi : 10.2337/dc22-1168
Psychiatric Morbidity in Women With Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study
Maria Hornstrup Christensen; Marianne Skovsager Andersen; Katrine Hass Rubin; Ellen Aagaard Nohr; Jori Aalders; Christina Anne Vinter; Dorte Moeller Jensen
doi : 10.2337/dc22-1961
Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased Genetic Risk of Cardiovascular Disease
Hyunsuk Lee; Jaewon Choi; Na Yeon Kim; Jong-Il Kim; Min Kyong Moon; Seunggeun Lee; Kyong Soo Park; Soo Heon Kwak
doi : 10.2337/dc22-2144
People With Type 1 Diabetes of African Caribbean Ethnicity Are at Increased Risk of Developing Sight-Threatening Diabetic Retinopathy
Anastasios Mangelis; Piyumi Wijewickrama; Abbeyramei Nirmalakumaran; Nikolaos Fountoulakis; Prashanth Vas; Laura Webster; Samantha Mann; Julian Collins; David Hopkins; Stephen Thomas; Salma Ayis; Janaka Karalliedde
doi : 10.2337/dc22-2118
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies
Jay M. Sosenko; David Cuthbertson; Emily K. Sims; Heba M. Ismail; Brandon M. Nathan; Laura M. Jacobsen; Mark A. Atkinson; Carmella Evans-Molina; Kevan C. Herold; Jay S. Skyler; Maria J. Redondo; TrialNet Study Group
doi : 10.2337/dc22-2236
Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
José Ignacio MartÃnez-Montoro; MarÃa José Picón-César; VÃctor José Simón-Frapolli; José Luis Pinzón-MartÃn; Jorge GarcÃa-Alemán; MarÃa Durán-MartÃnez; Francisco J. Tinahones
doi : 10.2337/dc23-0083
Potential and Pitfalls of ChatGPT and Natural-Language Artificial Intelligence Models for Diabetes Education
Gerald Gui Ren Sng; Joshua Yi Min Tung; Daniel Yan Zheng Lim; Yong Mong Bee
doi : 10.2337/dc23-0197
Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634–641
Xiaoni Meng; Youxin Wang
doi : 10.2337/dc22-0774
Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634–641
Carlos A. Celis-Morales; Bjorn Eliasson; Naveed Sattar
doi : 10.2337/dci22-0026
Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561–2569
Jingli Yang; Juwel Rana; Aimin Yang
doi : 10.2337/dc22-2140
Response to Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561–2569
Marta Galvez-Fernandez; Ana Navas-Acien
doi : 10.2337/dci22-0060
Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475
Ashwini D. Sharan; John A. Hatheway; Melissa Murphy; Tammy Dann; Michael A. Fishman; Xander Zuidema; Jan H.M. van Zundert; Maddie LaRue; Rachel Slangen
doi : 10.2337/dc22-2491
Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475
Behnam Sadeghirad; Xiaoqin Wang; Jason W. Busse
doi : 10.2337/dc22-2449
Response to Comment on Duarte et al. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475
Rui V. Duarte; Sarah Nevitt; Sue Copley; Michelle Maden; Cecile C. de Vos; Rod S. Taylor; Sam Eldabe
doi : 10.2337/dci23-0008
Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137
Ninon Foussard; Alice Larroumet; Amandine Ferrière; Laurence Blanco; Kamel Mohammedi; Vincent Rigalleau
doi : 10.2337/dc23-0070
Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137
Mengyao Tang; Sahir Kalim
doi : 10.2337/dci23-0011
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Ronald M. Goldenberg; Akshay B. Jain
doi : 10.2337/dc22-2300
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Mayumi Endo; Mara Y. Roth; Tracy S. Tylee; Anthony DeSantis; Irl B. Hirsch
doi : 10.2337/dc22-2454
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Ana B. Mañas-Martinez; Jose A. Gimeno-Orna
doi : 10.2337/dc23-0076
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Mark M. Smits; Daniël H. van Raalte
doi : 10.2337/dc23-0134
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Julien Bezin; Clément Mathieu; Jean-Luc Faillie; Antoine Pariente
doi : 10.2337/dci23-0016
Erratum. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S19–S40
Nuha A. ElSayed; Grazia Aleppo; Vanita R. Aroda; Raveendhara R. Bannuru; Florence M. Brown; Dennis Bruemmer; Billy S. Collins; Marisa E. Hilliard; Diana Isaacs; Eric L. Johnson; Scott Kahan; Kamlesh Khunti; Jose Leon; Sarah K. Lyons; Mary Lou Perry; Priya Prahalad; Richard E. Pratley; Jane Jeffrie Seley; Robert C. Stanton; Robert A. Gabbay; on behalf of the American Diabetes Association
doi : 10.2337/dc23-er05
